Type 1 Diabetes Mellitus: Etiology, Pathogenesis, Diagnosis, Disease Staging, Prevention with Teplizumab, and Emerging Beta-Cell Replacement Therapies
Journal of Medical Clinical Case Reports · 11.07.2026
DOI: 10.47485/2767-5416.1154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Clinical Case Reports, online erschienen am 11.07.2026. Verfasst von Andre Manov. Die Arbeit nennt 10 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease marked by immune-mediated destruction of pancreatic β-cells, leading to absolute insulin deficiency. Historically, diagnosis occurred only after the onset of hyperglycemia and clinical symptoms. Advances in immunology and genetics have revealed presymptomatic stages of the disease, enabling earlier identification of individuals at risk. Teplizumab, an anti-CD3 monoclonal antibody, is the first disease-modifying therapy shown to delay progression to clinical diabetes. In parallel, stem cell-derived β-cell replacement therapies and islet transplantation are opening new possibilities for restoring endogenous insulin production. This article reviews the etiology, pathogenesis, diagnosis, staging, prevention strategies, and emerging curative approaches for T1DM.
Zitieren
APA
Manov, A. (2026). Type 1 Diabetes Mellitus: Etiology, Pathogenesis, Diagnosis, Disease Staging, Prevention with Teplizumab, and Emerging Beta-Cell Replacement Therapies. Journal of Medical Clinical Case Reports. https://doi.org/10.47485/2767-5416.1154
Vancouver
Manov A. Type 1 Diabetes Mellitus: Etiology, Pathogenesis, Diagnosis, Disease Staging, Prevention with Teplizumab, and Emerging Beta-Cell Replacement Therapies. Journal of Medical Clinical Case Reports. 2026. doi:10.47485/2767-5416.1154
BibTeX
@article{Manov2026,
author = {Manov, Andre},
title = {Type 1 Diabetes Mellitus: Etiology, Pathogenesis, Diagnosis, Disease Staging, Prevention with Teplizumab, and Emerging Beta-Cell Replacement Therapies},
journal = {Journal of Medical Clinical Case Reports},
year = {2026},
doi = {10.47485/2767-5416.1154}
}
EUVIMED